JPRN-UMIN000007635Completed未知
Efficacy of linagliptin on glycemic control in diabetic patients on hemodialysis [Diamond study-1] - Efficacy of linagliptin in diabetic patients on hemodialysis [Diamond study-1]
Diamond study group0 sites80 target enrollmentStarted: April 2, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients treated with insulin Patients with severe liver dysfunction (AST >= 100 IU/L or ALT >= 100 IU/L) Patients with malignancy Patients with untreated diabetic retinopathy Patients disqualified by doctor for any reason
Investigators
Similar Trials
Completed
Not Applicable
Safety and efficacy of linagliptin for glycemic control in non-critically ill hospitalized patients with type 2 diabetesJPRN-UMIN000034778Ichinomiyanishi Hospital60
Completed
Phase 4
Efficacy of Sitagliptin on glycaemic control in drug naïve patients with type 2 diabetes (STRICT-2)Type 2 Diabetes MellitusJPRN-UMIN000005460STRICT study Group300
Not yet recruiting
Phase 3
Efficiency of linagliptin on insulin dosage in type 2 diabetes patientsType 2 diabetes.Type 2 diabetes mellitusIRCT20210609051526N1Babol University of Medical Sciences96
Completed
Not Applicable
Effects of Linagliptin on Hypoglycemia :Hypoglycemic Clamp Test in Japanese T2DM PatientsType 2 diabetesJPRN-UMIN000014417Kansai Electric Power Hospital35
Completed
Not Applicable
Effect of Linagliptin on daily glucose excursion in Continuous Glucose Monitoring of Type2 diabetic patientsType 2 DiabetesJPRN-UMIN000010880Japan society of Patient Reported Outcome100